62 related articles for article (PubMed ID: 4074444)
1. [The action of a new calcium antagonist 5,6-dimethoxy-2-(3 [(alpha-(3,4-dimethoxy)-phenylethyl)methylamino] propyl)-phthalimidine hydrochloride (AQ-A 39cl) on hemodynamics and ischemia parameters in exercise ECG of patients with coronary heart disease].
Jost S; Schulz W; Kober G
Arzneimittelforschung; 1985; 35(8):1279-82. PubMed ID: 4074444
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular actions of 5,6-dimethoxy-2-(3-[(alpha-(3,4-dimethoxy) phenylethyl)-methylamino] propyl) phthalimidine (AQ-A 39), a specific bradycardic agent.
Dämmgen J; Kadatz R; Diederen W
Arzneimittelforschung; 1981; 31(4):666-70. PubMed ID: 7195712
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular responses to increasing plasma concentrations of AQ-A 39 Cl, a new compound with negative chronotropic effects.
Verdouw PD; Bom HP; Bijleveld RE
Arzneimittelforschung; 1983; 33(5):702-6. PubMed ID: 6683548
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of two specific bradycardic agents AQ-A39 (falipamil) and AQ-AH 208 on reversible myocardial reperfusion damage in anesthetized dogs.
Gross GJ; Daemmgen JW
J Pharmacol Exp Ther; 1986 Aug; 238(2):422-8. PubMed ID: 3735124
[TBL] [Abstract][Full Text] [Related]
5. AQ-A 39 (5,6-dimethoxy-2-[3[[alpha-(3,4-dimethoxy)-phenylethyl]methylamino]propyl]phtalimidine), a specific bradycardic agent with direct action on the heart.
Kobinger W; Lillie C
Eur J Pharmacol; 1981 Jun; 72(2-3):153-64. PubMed ID: 7250205
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of perioperative sinus tachycardia with the new calcium antagonist falipamil].
Tryba M; Zenz M
Arzneimittelforschung; 1987 Nov; 37(11):1298-300. PubMed ID: 3440040
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
Schnellbacher K; Bestehorn HP; Roskamm H
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological studies on effects of AQ-A 39 in the isolated guinea pig heart and myocardial preparations.
Hohnloser S; Weirich J; Homburger H; Antoni H
Arzneimittelforschung; 1982; 32(7):730-4. PubMed ID: 6889873
[TBL] [Abstract][Full Text] [Related]
9. Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris.
Dorow P; Schiess W
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):419-22. PubMed ID: 6386704
[TBL] [Abstract][Full Text] [Related]
10. Exercise testing in the evaluation of coronary artery disease.
Ellestad MH; Famularo MA; Paliwal YK
Herz; 1982 Apr; 7(2):76-90. PubMed ID: 6979501
[TBL] [Abstract][Full Text] [Related]
11. [Antianginal effect of calcium antagonists, using nisoldipine as an example].
Hess OM; Krayenbühl HP
Schweiz Med Wochenschr; 1984 Aug; 114(33):1126-31. PubMed ID: 6484542
[TBL] [Abstract][Full Text] [Related]
12. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
[TBL] [Abstract][Full Text] [Related]
14. [Effect of the prostacyclin analog taprostene on ischemic ST-segment depression in the stress ECG of coronary patients].
Hopf R; Schöfl E; Frings M; Söhngen W
Z Kardiol; 1994 Apr; 83(4):258-63. PubMed ID: 8023538
[TBL] [Abstract][Full Text] [Related]
15. [Dose-response relationship of nisoldipine in patients with stable angina pectoris and stress-induced myocardial ischemia].
Grönefeld G; Bernhardt J; Schneider W
Z Kardiol; 1993 Sep; 82(9):573-8. PubMed ID: 8237098
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic actions on alinidine during exercise in patients with coronary artery disease.
Löllgen H; Just H; Wollschläger H; Kersting F
Z Kardiol; 1981 May; 70(5):425-8. PubMed ID: 7269729
[TBL] [Abstract][Full Text] [Related]
17. Sustained antianginal efficacy of oral high-dose isosorbide dinitrate in patients with coronary heart disease.
Schneider W; Wietschoreck A; Bussmann WD; Kaltenbach M
Z Kardiol; 1983; 72 Suppl 3():259-67. PubMed ID: 6666231
[TBL] [Abstract][Full Text] [Related]
18. [Heart rate behavior and the ischemic ST-segment under carteolol hydrochloride. Dose-response relationship and duration of effect].
Kober G; Veidt J; Mikludy R; Kaltenbach M
Arzneimittelforschung; 1983; 33(2a):313-7. PubMed ID: 6682323
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
Rousseau MF; Pouleur H; Cocco G; Wolff AA
Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
[TBL] [Abstract][Full Text] [Related]
20. Immediate and longer-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease.
Visser CA; Jaarsma W; Kan G; Lie KI
Postgrad Med J; 1984; 60 Suppl 4():17-20. PubMed ID: 6527974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
